RSV Vaccine

• Redemption within 3 months from the date of purchase. 

• No appointment is needed, please proceed to the Pharmacy counter:
  • LifeCare Bangsar South – Level 1 
  • LifeCare Cheras South – Level 2 

• Tell your doctor, nurse, or pharmacist before you receive the vaccine if you:
  • are allergic to the active ingredients or any of the other ingredients in this vaccine. 
  • are suffering from an illness. 
  • have a bleeding problem or bruise easily. 
  • ever fainted from an injection. 

• LifeCare reserves the right to amend the terms & conditions without prior notice. 

RSV Infection: What You Need to Know 

Respiratory Syncytial Virus (RSV) is a highly contagious virus that can cause mild to severe respiratory symptoms. While RSV is often mistaken for a common cold, it can be more serious, especially for older adults and those with underlying health conditions. 

Symptoms of RSV 

RSV symptoms can last up to two weeks and may include: 
✔ Fever 
✔ Runny nose 
✔ Cough 
✔ Sneezing 
✔ Sore throat 
✔ Wheezing 
✔ Congestion 
✔ Rapid or difficult breathing 
✔ Headache 
✔ Fatigue 
✔ Cyanosis (bluish skin due to lack of oxygen) 

RSV Risks for Older Adults 

Adults aged 60 and above are at a higher risk of severe RSV infections, which can lead to hospitalization. RSV can also worsen existing conditions such as: 
✔ Pneumonia 
✔ Congestive heart failure (CHF) 
✔ Asthma 
✔ Chronic obstructive pulmonary disease (COPD) 

Even after recovery, RSV may cause long-term effects, making daily tasks like eating, walking, and breathing more challenging. 

Who Is at Higher Risk? 

Older adults and those with health conditions like diabetes, COPD, heart disease, and asthma are more likely to be hospitalized due to RSV complications. 

How to Prevent RSV 

✔ Wash your hands regularly 
✔ Avoid touching your face 
✔ Keep distance from sick individuals 
✔ Cover coughs and sneezes 
✔ Clean and disinfect surfaces 
✔ Stay home if you’re unwell 

RSV Vaccination for Protection 

A vaccine is available to help protect older adults from severe RSV infections. Studies show: 

✔ 82.6% efficacy in preventing RSV-related lower respiratory diseases 
✔ 94.6% efficacy in individuals with at least one underlying condition